Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.

The Netherlands journal of medicine - 1 Dec 1995

Clarysse C, Van den Eynde C, Nevens F, Portier C, Aelbrecht N, Fevery J, Yap S H

Abstract excerpt

OBJECTIVE: Since only a small proportion of patients with chronic hepatitis C benefit from interferon therapy, we assessed the viral factors such as HCV genotype and the level of viraemia for prediction of interferon response. METHODS: HCV genotype and serum levels of HCV-RNA were determined in 2...

Topics

Adolescent
Adult
Aged
Alanine Transaminase
Antiviral Agents
Chronic Disease
Drug Monitoring
Female
Genotype
Hepacivirus
Hepatitis C
Humans
Interferon alpha-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Interferon-alpha

Male

Middle Aged

RNA, Viral

Recombinant Proteins

Source

Identifiers

PMID: 8569931
DOI: 10.1016/0300-2977(95)00101-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8569931-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.PMID 8569931Read ↗

Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy.Semantic proximity Read ↗

HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).Semantic proximity Read ↗

Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.Semantic proximity Read ↗

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.Semantic proximity Read ↗

Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.Semantic proximity Read ↗

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus genotype, hepatitis C virus RNA titers, and response to interferon.Semantic proximity Read ↗

Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.Semantic proximity Read ↗

Chronic hepatitis C treated with peginterferon alfa plus ribavirin in clinical practice.Semantic proximity Read ↗

Should we test hepatitis C virus genotype and viraemia level in patients with chronic hepatitis C?Semantic proximity Read ↗

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.